Stock futures pointed to a weaker open Tuesday after equities closed lower Monday, pausing Wall Street's rally in November.
These stocks were poised to make moves Tuesday:
Zscaler reported fiscal first-quarter adjusted earnings, revenue, and calculated billings that beat analysts' expectations and the cybersecurity company issued a forecast for the second quarter that also topped estimates. Zscaler shares, however, were falling 6.1% in premarket trading as the company maintained its fiscal-year forecast for calculated billings at $2.52 billion to $2.56 billion versus estimates of $2.54 billion. Competitor CrowdStrike Holdings, which is scheduled to report earnings after the closing bell Tuesday, was down 1.4%.
Earnings reports are also expected Tuesday from Intuit, Workday, Splunk, Hewlett Packard Enterprise, NetApp, and PDD Holdings.
Acelyrin disclosed there was a programming error in a drug trial of izokibep, a treatment for psoriatic arthritis. Acelyrin said the protocol was programmed incorrectly by a vendor, "resulting in a sequencing error that went further unidentified through the providers' testing processes." The company said it has addressed the programming error. Shares of the biopharmaceutical company fell 8.2% in after-hours trading Monday.
iRobot was rising 1.5% in premarket trading after tumbling 17% on Monday following a "statement of objections" from the European Commission to the Roomba vacuum cleaner company's pending deal to be acquired by Amazon.com. The EC said it was concerned the acquisition could restrict competition in the European market for robotic vacuum cleaners.
Faraday Future Intelligent Electric Inc. gained over 4% in premarket trading as it received over 300 nonbinding no-deposit reservations for the FF 91 2.0 Futurist aiFalcon limited edition. Additionally, FF said it plans to introduce the FF 91 2.0 Futurist aiFalcon Limited Edition to the Middle East market as early as 2024.
AMTD Digital Inc. fell over 5% in premarket trading. AMTD Digital Inc., together with AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Group Inc., through AMTD World Media and Entertainment Group, are thrilled to announce the launch of L'Officiel Hong Kong. The digital platform is now launched together with the print magazine which is expected to hit the market in early 2024.
Redhill Biopharma continued to rise 18% in premarket trading. The U.S. Food and Drug Administration (FDA) granted five years' market exclusivity for Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, the company said in a statement.
Comments